David Aaron Lehman Insider Profile
4 Followers
David Aaron Lehman, SVP & GC at Thoratec Corp, holds 376.16K shares in Pulmonx (Ticker: LUNG), holds 79.20K shares in Intersect ENT (Ticker: XENT), holds 0.00 shares in Thoratec Corp (Ticker: ~THOR). Most recently, David Aaron Lehman Sold ― shares of Pulmonx on Jun 03, 2026 for an estimated value of $22.47K.
Profitable Transactions
19 out of 20 Profitable Transactions
Average Return
+35.40%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of David Aaron Lehman's holdings
Insider Roles
GC
Roles that David Aaron Lehman holds in companies
Most Profitable Insider Trade
The most profitable trade made by David Aaron Lehman
David Aaron Lehman's Trading History
Thoratec Corp
Oct 08, 2015
―
Uninformative Buy
―
$0.00
Intersect ENT
Feb 05, 2020
―
Uninformative Buy
―
$2.24M
Pulmonx
Jun 03, 2026
GC
Informative Sell
22.47K
$481.49K
List of latest transactions for each holding click on a transaction to see David Aaron Lehman's performance on stock
You May Also Like
David Aaron Lehman insider profile FAQ
What is the percentage of profitable transactions made by David Aaron Lehman?
The percentage of profitable transactions made by David Aaron Lehman is 95%.
What is the average return per transaction made by David Aaron Lehman?
The average return per transaction made by David Aaron Lehman is 35.40%.
What stocks does David Aaron Lehman hold?
David Aaron Lehman holds: ~THOR, XENT, LUNG stocks.
What was David Aaron Lehman’s latest transaction?
David Aaron Lehman latest transaction was an Informative Sell of $22.47K.
What was David Aaron Lehman's most profitable transaction?
David Aaron Lehman’s most profitable transaction was an Informative Sell of LUNG stock on March 5, 2025. The return on the trade was 80.30%.
What is David Aaron Lehman's role in Thoratec Corp?
David Aaron Lehman's role in Thoratec Corp is SVP & GC.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.